Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013, 157(4):311-315 | DOI: 10.5507/bp.2012.095
The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions
- a Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic
- b Department of Clinical Immunology and Allergy, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove
Background: Malignant pleural effusions accumulate in the space between the visceral (inner) layer covering the lungs and the parietal (outer) layer covering the chest wall. Larger effusions compress the pulmonary parenchyma resulting in increasing dyspnoea. Treatment is always local and palliative. Among others, chemical pleurodesis using talc can be performed in selected patients. Talc is hydrated magnesium silicate (chemically H2Mg3(SiO3)4) and has been used for pleurodesis since 1935. Videothoracoscopic talc powder insufflation (talc poudrage) is the most effective.However, markers of inflammatory reactions to extraneous substances like talc are not fully understood. The aim of this study was to assess the course of local inflammatory changes in the pleural cavity after talc insufflation.
Methods: The Department of Cardiac Surgery of the Faculty of Medicine and University Hospital in Hradec Kralove, treated 47 patients aged 65 on average; 29 males and 18 females with proven recurrent malignant pleural effusion of various aetiologies from January 2009 to December 2010. They were retrospectively divided into group A (40 patients) without recurring effusion, and group B (7 patients) with recurring effusion and the need for thoracentesis or chest drainage during the 9-month monitoring.
Results: Major findings were made in soluble forms of cell receptors. Group B showed statistically higher levels of the anti-inflammatory form of sCD-163 receptor in pleural fluid before the talc poudrage. This showed limited ability to create an adequate inflammatory response to external stimuli. This group also showed lower levels of the inflammatory form of sTLR-2 receptor immediately after the talc insufflation. This revealed low local reactivity to external stimuli. The effect of the treatment was not influenced by morphologic tumour type. No statistically significant differences in postoperative complications were found. This confirmed the safety of both videothoracoscopy and treatment.
Conclusions: There was no correlation between the type of malignant affection and the outcome of the chemical pleurodesis. Patients with relapsing effusion have higher values of concentration of anti-inflammatory sCD-163 in pleural fluid even before the application of talc, and lower levels of concentration of inflammatory sTLR-2 immediately after application of talc.
Keywords: malignant pleural effusion,thoracoscopy, talc, sCD-163, sTLR-2
Received: May 9, 2012; Accepted: October 8, 2012; Prepublished online: December 7, 2012; Published: December 12, 2013 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Miserocchi G. Physiology of pleural fluid turnover. Eur Respir J 1997;10:219-25.
Go to original source...
Go to PubMed... - Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D. Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J ClinOncol 2010;33:420-3.
Go to original source... - Jantz MA, Antony VB. Pathophysiology of the pleura. Respiration 2008;75:121-33.
Go to original source...
Go to PubMed... - Froudarakis ME, Klimathianaki M, Pougounias M. Systemic Inflammatory Reaction After Thoracoscopic Talc Poudrage. Chest 2006;129:356-61.
Go to original source...
Go to PubMed... - Marel M, Zrustova M, Stastny B. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 1993;104:1486-9.
Go to original source...
Go to PubMed... - Schag CC, Heinrich Ganz PA. Karnofsky performance status revisited. Reliability, validity, and guidelines. J Clin Oncology 1984;2:187-93.
Go to original source...
Go to PubMed... - Montes JF, Ferrer J, Villarino MA. Influence of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J Respir Crit Care Med 2003;168:348-55.
Go to original source...
Go to PubMed... - Idell S. The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med 2008;14:310-5.
Go to original source...
Go to PubMed... - Huggins JT, Doelken P, Sahn SA. The unexpadable lung. Med Rep 2010;2:77.
Go to original source... - Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, Loddenkemper R, Herth FJ, Gasparini S, Marquette CH, Becke B, Froudarakis ME, Driesen P, Bolliger CT, Tschopp JM: Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-9.
Go to original source...
Go to PubMed... - Rodriguez-Panadero F, Montes-Worboys A. Mechanisms of pleurodesis. Respiration 2012;83:91-8.
Go to original source...
Go to PubMed... - Marchi E, Vargas FS, Acencio MMP, Teixeira LR, Antonangelo L, Lee YCG, Light RW. Pleurodesis: A novel experimental model.Respirology 2007;12(4):500-4.
Go to original source...
Go to PubMed... - Webb HE, Osten SW.Treatment of malignant ascites and pleural effusions with Corynebacterium parvum. Br Med J 1978;1:338-40.
Go to original source...
Go to PubMed... - Hoffeld JT. Inhibition of lymphocyte proliferation and antibody production in vitro by silica, talc, bentonite or Corynebacterium parvum: involment of peroxidative processes. Eur J Immunol 1983;13:364-9.
Go to original source...
Go to PubMed... - Dresler CM, Olak J, James E. Herndon JE, Richards WG, Scalzetti E, Fleishman SB, Kernstine KH, Demmy T, Jablons DM, Kohman L, Daniel TM, Sugarbaker DJ. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion. Chest 2005;127(3):909-15.
Go to original source...
Go to PubMed... - de Campos JR, Vargas FS, Werebe E. Thoracoscopic talc poudrage: a 15-year experience. Chest 2001;119:801-6.
Go to original source...
Go to PubMed... - Davies R, Skidmore JW, Griffiths DM, Moncrieff CB: Cytotoxicity of talc for macrophages in vitro. Food Chem Toxicol 1983;21:201-7.
Go to original source...
Go to PubMed... - Idris L, Ranaweera N, Laws D. Investigation of pleural effusions. Acute Med 2011;10:216-20.
Go to original source...
Go to PubMed... - Porcel JM. Pearls and myths in pleural fluid analysis. Respirology 2011;16:44-52.
Go to original source...
Go to PubMed... - Rodriquez-Panadero F, Lopez-Mejitaz J. Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Chest 1989;95:320-4.
Go to original source...
Go to PubMed... - Heffner JE, Nietert P, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data. Chest 2000;117:87-95.
Go to original source...
Go to PubMed... - Huseyin Y, Muzaffer M, Selma M, Sinan E. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions. Lung Cancer 2008;62:139-44.
Go to original source...
Go to PubMed... - Uzbeck MH, Almeida FA, Sarkiss MG, Morice RC, Jimenez CA, Eapen GA, Kennedy MP. Management of malignant pleural effusions. Adv Ther 2010;27:334-7.
Go to original source...
Go to PubMed... - Bielsa S, Hernandez P, Panadero FR, Taberner T, Salud A, Porcel JM. Tumor Type Influences the Effectiveness of Pleurodesis in. Malignant Effusions Lung 2011;189(2):151-5.
Go to original source...
Go to PubMed... - Acencio MMP, Vargas FS, Marchi E, Carnevale GG, Teixeira LR, Antonangelo L, Broaddus VG. Pleural Mesothelial Cells Mediate Inflammatory and Profibrotic Responses in Talc-induced Pleurodesis. Lung 2007;185(6):343-8.
Go to original source...
Go to PubMed... - Razonable RR, Henault M, Paya CV. Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines. Toxicol Appl Pharmacol 2006;210:181-9.
Go to original source...
Go to PubMed... - van den Heuvel MM, Smit HJ, Barbierato SB, Havenith CE, Beelen RH, Postmus PE. Talc-induced inflammation in the pleural cavity. Eur Respir J 1998;12:1419-23.
Go to original source...
Go to PubMed... - Nasreen N, Hartman DL, Mohammed KA, Antony VB. Talc-induced expression on C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells. Am J Respir Crit Care Med 1998;158:971-8.
Go to original source...
Go to PubMed... - Antony VB, Nasreen N, Mohammed KA, Sriram PS, Frank W, Schoenfeld N, Loddenkemper R. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest 2001;126:1522-8.
Go to original source... - Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-6.
Go to original source...
Go to PubMed... - Sirisinha S. Insight into the mechanisms regulating immune homeostasis in health and disease. Asian Pac J Allergy Immunol 2011;29:1-14.
Go to PubMed... - Montes-Worboys A, Rodriguez-Potal JA, Arellano-Orden E, Digon-Pereiras J, Rodriguez-Panadero F. Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis. EurRespir J 2010;35:160-6.
Go to original source... - Delongu G, Moretti S, Antonucci A. Apoptosis and surgical trauma. Arch Surg 2000;135:1141-7.
Go to original source...
Go to PubMed... - Christensen R, Bradley PP, Rothstein G. The leukocyte left shift in clinical and experimental neonatal sepsis. J Pediatr 1981;98:101.
Go to original source...
Go to PubMed... - Levy JH, Tanak KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:715-20.
Go to original source...
Go to PubMed... - Akbas H, Erdal C, Demiralp E, Alp M. Effectsofcoronaryartery bypass grafting on cellular immunity with or without cardiopulmonary bypass: changes in lymphocytes subsets. Cardiovasc Surg 2002;10(6):586-9.
Go to original source...
Go to PubMed... - Yang HB, Xie KQ, Deng JM, Qin SM. Expression of soluble Toll-like receptors in pleural effusions. Chin Med J 2010;123:2225-30.
- Chang LC, Hua CC, Chu CM, Chiang BY, Chen HJ, Yu CC. Differential mRNA expression of Toll-like receptors and their adaptors in pleural effusions. Respirology 2009;14:1194-9.
Go to original source...
Go to PubMed... - Acorci-Valerio MJ, Bordon-Graciani AP, Dias-Melicio LA, de Assis Golim M, Nakaira-Takahagi E, de Campos Soares AM. Role of TLR2 and TLR4 in human neutrophil functions against Paracoccidioides brasiliensis. Scanc J Immunol 2010;71:99-108.
Go to original source... - Hidaka M, Fukuzawa K. Down-modulation of toll-like receptor 2 expression on granulocytes and suppression of interleukin-8 production due to in vitro treatment with cellulose acetate beads. Ther Apher Dial 2011;15:572-8.
Go to original source...
Go to PubMed... - Krejsek J, Kunes P, Kolackova M, Kudlova M, Lonsky V, Mandak J, Andrys C. Expression of Toll-like receptors 2 and 4 on innate immunity cells modulated by cardiac surgical operation. Scand J Clin Lab Invest 2008;68:749-58.
Go to original source...
Go to PubMed... - Onofre G, Kolackova M, Jankovicova K. Scavenger receptor cd163 and its biological functions. Acta medica (Hradec Kralove) 2009;52(2):57-61.
Go to original source...
Go to PubMed... - Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 2010;87:989-99.
Go to original source...
Go to PubMed...




